nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Propranolol—migraine	0.0828	0.247	CbGbCtD
Pimecrolimus—CYP3A4—Amitriptyline—migraine	0.0716	0.214	CbGbCtD
Pimecrolimus—CYP3A4—Valproic Acid—migraine	0.0652	0.195	CbGbCtD
Pimecrolimus—CYP3A4—Topiramate—migraine	0.0589	0.176	CbGbCtD
Pimecrolimus—CYP3A4—Verapamil—migraine	0.0568	0.169	CbGbCtD
Pimecrolimus—MTOR—EGFR-dependent Endothelin signaling events—EDNRA—migraine	0.0108	0.0856	CbGpPWpGaD
Pimecrolimus—MTOR—blood vessel—migraine	0.0106	0.142	CbGeAlD
Pimecrolimus—MTOR—Type II diabetes mellitus—CACNA1A—migraine	0.01	0.0797	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFBR2—migraine	0.00936	0.0745	CbGpPWpGaD
Pimecrolimus—FKBP1A—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MEF2D—migraine	0.00934	0.0743	CbGpPWpGaD
Pimecrolimus—MTOR—neck—migraine	0.00757	0.102	CbGeAlD
Pimecrolimus—FKBP1A—neck—migraine	0.00681	0.0914	CbGeAlD
Pimecrolimus—FKBP1A—ALK1 signaling events—TGFBR2—migraine	0.00635	0.0505	CbGpPWpGaD
Pimecrolimus—FKBP1A—trigeminal ganglion—migraine	0.00588	0.0789	CbGeAlD
Pimecrolimus—MTOR—brainstem—migraine	0.00578	0.0776	CbGeAlD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFBR2—migraine	0.00538	0.0428	CbGpPWpGaD
Pimecrolimus—MTOR—cardiovascular system—migraine	0.00472	0.0633	CbGeAlD
Pimecrolimus—MTOR—IL4-mediated signaling events—LTA—migraine	0.0047	0.0374	CbGpPWpGaD
Pimecrolimus—FKBP1A—cardiovascular system—migraine	0.00424	0.057	CbGeAlD
Pimecrolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.00386	0.0307	CbGpPWpGaD
Pimecrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.00378	0.0301	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—TGFBR2—migraine	0.00365	0.029	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—TGFBR2—migraine	0.00354	0.0281	CbGpPWpGaD
Pimecrolimus—MTOR—FSH signaling pathway—BDNF—migraine	0.00333	0.0265	CbGpPWpGaD
Pimecrolimus—MTOR—head—migraine	0.00319	0.0429	CbGeAlD
Pimecrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR2—migraine	0.00318	0.0253	CbGpPWpGaD
Pimecrolimus—MTOR—nervous system—migraine	0.00303	0.0407	CbGeAlD
Pimecrolimus—MTOR—central nervous system—migraine	0.00292	0.0392	CbGeAlD
Pimecrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFBR2—migraine	0.00287	0.0229	CbGpPWpGaD
Pimecrolimus—FKBP1A—head—migraine	0.00287	0.0386	CbGeAlD
Pimecrolimus—MTOR—cerebellum—migraine	0.00285	0.0383	CbGeAlD
Pimecrolimus—FKBP1A—nervous system—migraine	0.00272	0.0366	CbGeAlD
Pimecrolimus—FKBP1A—central nervous system—migraine	0.00262	0.0352	CbGeAlD
Pimecrolimus—FKBP1A—cerebellum—migraine	0.00256	0.0344	CbGeAlD
Pimecrolimus—Skin discolouration—Topiramate—migraine	0.00237	0.00509	CcSEcCtD
Pimecrolimus—Dysmenorrhoea—Topiramate—migraine	0.00235	0.00506	CcSEcCtD
Pimecrolimus—Pharyngitis—Propranolol—migraine	0.00234	0.00504	CcSEcCtD
Pimecrolimus—MTOR—brain—migraine	0.00232	0.0311	CbGeAlD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—FOS—migraine	0.0023	0.0183	CbGpPWpGaD
Pimecrolimus—Sinusitis—Verapamil—migraine	0.00227	0.00488	CcSEcCtD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.00218	0.0174	CbGpPWpGaD
Pimecrolimus—Rhinitis—Verapamil—migraine	0.00217	0.00468	CcSEcCtD
Pimecrolimus—Nasal congestion—Timolol—migraine	0.00217	0.00468	CcSEcCtD
Pimecrolimus—Ear pain—Gabapentin—migraine	0.00216	0.00465	CcSEcCtD
Pimecrolimus—Pharyngitis—Verapamil—migraine	0.00215	0.00463	CcSEcCtD
Pimecrolimus—Face oedema—Valproic Acid—migraine	0.00215	0.00462	CcSEcCtD
Pimecrolimus—Dermatitis exfoliative—Timolol—migraine	0.0021	0.00452	CcSEcCtD
Pimecrolimus—Swelling—Gabapentin—migraine	0.00209	0.0045	CcSEcCtD
Pimecrolimus—FKBP1A—brain—migraine	0.00208	0.028	CbGeAlD
Pimecrolimus—Gastroenteritis—Gabapentin—migraine	0.00208	0.00448	CcSEcCtD
Pimecrolimus—Influenza like illness—Topiramate—migraine	0.00207	0.00447	CcSEcCtD
Pimecrolimus—Oedema—Amitriptyline—migraine	0.00206	0.00443	CcSEcCtD
Pimecrolimus—Erythema—Propranolol—migraine	0.00205	0.00442	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Valproic Acid—migraine	0.00203	0.00437	CcSEcCtD
Pimecrolimus—Flushing—Verapamil—migraine	0.00201	0.00433	CcSEcCtD
Pimecrolimus—Breast disorder—Valproic Acid—migraine	0.00201	0.00432	CcSEcCtD
Pimecrolimus—Influenza—Valproic Acid—migraine	0.00192	0.00414	CcSEcCtD
Pimecrolimus—Bronchitis—Valproic Acid—migraine	0.00185	0.00398	CcSEcCtD
Pimecrolimus—Paraesthesia—Amitriptyline—migraine	0.00185	0.00398	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—BDNF—migraine	0.00182	0.0145	CbGpPWpGaD
Pimecrolimus—Ear pain—Topiramate—migraine	0.00182	0.00391	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Timolol—migraine	0.00181	0.00389	CcSEcCtD
Pimecrolimus—Cough—Propranolol—migraine	0.00179	0.00386	CcSEcCtD
Pimecrolimus—Breast disorder—Timolol—migraine	0.00179	0.00385	CcSEcCtD
Pimecrolimus—Face oedema—Gabapentin—migraine	0.00178	0.00383	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Timolol—migraine	0.00177	0.00381	CcSEcCtD
Pimecrolimus—Constipation—Amitriptyline—migraine	0.00176	0.00379	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Valproic Acid—migraine	0.00175	0.00378	CcSEcCtD
Pimecrolimus—Gastroenteritis—Topiramate—migraine	0.00175	0.00377	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.00174	0.00374	CcSEcCtD
Pimecrolimus—Angioedema—Verapamil—migraine	0.00173	0.00371	CcSEcCtD
Pimecrolimus—Pneumonia—Valproic Acid—migraine	0.00172	0.00371	CcSEcCtD
Pimecrolimus—MTOR—LKB1 signaling events—ESR1—migraine	0.00172	0.0137	CbGpPWpGaD
Pimecrolimus—Asthma—Timolol—migraine	0.00171	0.00368	CcSEcCtD
Pimecrolimus—Nasal congestion—Topiramate—migraine	0.0017	0.00366	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Propranolol—migraine	0.00168	0.00361	CcSEcCtD
Pimecrolimus—Breast disorder—Gabapentin—migraine	0.00167	0.00359	CcSEcCtD
Pimecrolimus—Conjunctivitis—Valproic Acid—migraine	0.00167	0.00358	CcSEcCtD
Pimecrolimus—Infection—Propranolol—migraine	0.00166	0.00358	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Gabapentin—migraine	0.00165	0.00355	CcSEcCtD
Pimecrolimus—Nervous system disorder—Propranolol—migraine	0.00164	0.00354	CcSEcCtD
Pimecrolimus—Urticaria—Amitriptyline—migraine	0.00163	0.00352	CcSEcCtD
Pimecrolimus—Skin disorder—Propranolol—migraine	0.00163	0.0035	CcSEcCtD
Pimecrolimus—Body temperature increased—Amitriptyline—migraine	0.00163	0.0035	CcSEcCtD
Pimecrolimus—Epistaxis—Valproic Acid—migraine	0.00162	0.00348	CcSEcCtD
Pimecrolimus—MTOR—ErbB2/ErbB3 signaling events—FOS—migraine	0.00161	0.0128	CbGpPWpGaD
Pimecrolimus—Arthralgia—Verapamil—migraine	0.00161	0.00346	CcSEcCtD
Pimecrolimus—Sinusitis—Valproic Acid—migraine	0.00161	0.00346	CcSEcCtD
Pimecrolimus—Influenza—Gabapentin—migraine	0.00159	0.00343	CcSEcCtD
Pimecrolimus—Asthma—Gabapentin—migraine	0.00159	0.00343	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Timolol—migraine	0.00159	0.00342	CcSEcCtD
Pimecrolimus—Rhinitis—Valproic Acid—migraine	0.00154	0.00332	CcSEcCtD
Pimecrolimus—Oedema—Verapamil—migraine	0.00154	0.00332	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Verapamil—migraine	0.00154	0.00332	CcSEcCtD
Pimecrolimus—Bronchitis—Gabapentin—migraine	0.00153	0.0033	CcSEcCtD
Pimecrolimus—Infection—Verapamil—migraine	0.00153	0.0033	CcSEcCtD
Pimecrolimus—Pharyngitis—Valproic Acid—migraine	0.00153	0.00329	CcSEcCtD
Pimecrolimus—Paraesthesia—Propranolol—migraine	0.0015	0.00324	CcSEcCtD
Pimecrolimus—Face oedema—Topiramate—migraine	0.0015	0.00322	CcSEcCtD
Pimecrolimus—Dyspnoea—Propranolol—migraine	0.00149	0.00322	CcSEcCtD
Pimecrolimus—Conjunctivitis—Timolol—migraine	0.00148	0.00319	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Gabapentin—migraine	0.00148	0.00319	CcSEcCtD
Pimecrolimus—Pruritus—Amitriptyline—migraine	0.00146	0.00313	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Gabapentin—migraine	0.00145	0.00313	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Propranolol—migraine	0.00145	0.00311	CcSEcCtD
Pimecrolimus—Epistaxis—Timolol—migraine	0.00144	0.0031	CcSEcCtD
Pimecrolimus—Eye disorder—Valproic Acid—migraine	0.00144	0.00309	CcSEcCtD
Pimecrolimus—Constipation—Propranolol—migraine	0.00143	0.00308	CcSEcCtD
Pimecrolimus—Pain—Propranolol—migraine	0.00143	0.00308	CcSEcCtD
Pimecrolimus—Sinusitis—Timolol—migraine	0.00143	0.00308	CcSEcCtD
Pimecrolimus—Pneumonia—Gabapentin—migraine	0.00143	0.00308	CcSEcCtD
Pimecrolimus—MTOR—Type II diabetes mellitus—TNF—migraine	0.00143	0.0114	CbGpPWpGaD
Pimecrolimus—Infestation—Gabapentin—migraine	0.00142	0.00306	CcSEcCtD
Pimecrolimus—Infestation NOS—Gabapentin—migraine	0.00142	0.00306	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Topiramate—migraine	0.00142	0.00305	CcSEcCtD
Pimecrolimus—Diarrhoea—Amitriptyline—migraine	0.00141	0.00303	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Verapamil—migraine	0.0014	0.00302	CcSEcCtD
Pimecrolimus—Breast disorder—Topiramate—migraine	0.0014	0.00302	CcSEcCtD
Pimecrolimus—Immune system disorder—Valproic Acid—migraine	0.00139	0.00299	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Topiramate—migraine	0.00139	0.00298	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Valproic Acid—migraine	0.00139	0.00298	CcSEcCtD
Pimecrolimus—Paraesthesia—Verapamil—migraine	0.00138	0.00298	CcSEcCtD
Pimecrolimus—Conjunctivitis—Gabapentin—migraine	0.00138	0.00297	CcSEcCtD
Pimecrolimus—Dyspnoea—Verapamil—migraine	0.00137	0.00296	CcSEcCtD
Pimecrolimus—Rhinitis—Timolol—migraine	0.00137	0.00295	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Propranolol—migraine	0.00137	0.00295	CcSEcCtD
Pimecrolimus—Asthma—Topiramate—migraine	0.00134	0.00288	CcSEcCtD
Pimecrolimus—Epistaxis—Gabapentin—migraine	0.00134	0.00288	CcSEcCtD
Pimecrolimus—Malnutrition—Valproic Acid—migraine	0.00134	0.00288	CcSEcCtD
Pimecrolimus—Sinusitis—Gabapentin—migraine	0.00133	0.00287	CcSEcCtD
Pimecrolimus—Urticaria—Propranolol—migraine	0.00133	0.00286	CcSEcCtD
Pimecrolimus—Body temperature increased—Propranolol—migraine	0.00132	0.00285	CcSEcCtD
Pimecrolimus—Abdominal pain—Propranolol—migraine	0.00132	0.00285	CcSEcCtD
Pimecrolimus—Constipation—Verapamil—migraine	0.00132	0.00284	CcSEcCtD
Pimecrolimus—Pain—Verapamil—migraine	0.00132	0.00284	CcSEcCtD
Pimecrolimus—Vomiting—Amitriptyline—migraine	0.00131	0.00282	CcSEcCtD
Pimecrolimus—Rash—Amitriptyline—migraine	0.0013	0.00279	CcSEcCtD
Pimecrolimus—Dermatitis—Amitriptyline—migraine	0.0013	0.00279	CcSEcCtD
Pimecrolimus—Back pain—Valproic Acid—migraine	0.0013	0.00279	CcSEcCtD
Pimecrolimus—Headache—Amitriptyline—migraine	0.00129	0.00277	CcSEcCtD
Pimecrolimus—Bronchitis—Topiramate—migraine	0.00129	0.00277	CcSEcCtD
Pimecrolimus—Eye disorder—Timolol—migraine	0.00128	0.00275	CcSEcCtD
Pimecrolimus—Rhinitis—Gabapentin—migraine	0.00128	0.00275	CcSEcCtD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—FOS—migraine	0.00128	0.0101	CbGpPWpGaD
Pimecrolimus—Pharyngitis—Gabapentin—migraine	0.00127	0.00272	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Topiramate—migraine	0.00125	0.00268	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.00124	0.00986	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—migraine	0.00124	0.00984	CbGpPWpGaD
Pimecrolimus—Immune system disorder—Timolol—migraine	0.00124	0.00266	CcSEcCtD
Pimecrolimus—Hypersensitivity—Propranolol—migraine	0.00123	0.00266	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Timolol—migraine	0.00123	0.00266	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—FOS—migraine	0.00123	0.00979	CbGpPWpGaD
Pimecrolimus—Urticaria—Verapamil—migraine	0.00122	0.00264	CcSEcCtD
Pimecrolimus—Angioedema—Valproic Acid—migraine	0.00122	0.00263	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Topiramate—migraine	0.00122	0.00263	CcSEcCtD
Pimecrolimus—Nausea—Amitriptyline—migraine	0.00122	0.00263	CcSEcCtD
Pimecrolimus—Pneumonia—Topiramate—migraine	0.0012	0.00259	CcSEcCtD
Pimecrolimus—Infestation—Topiramate—migraine	0.00119	0.00257	CcSEcCtD
Pimecrolimus—Infestation NOS—Topiramate—migraine	0.00119	0.00257	CcSEcCtD
Pimecrolimus—MTOR—Regulation of Telomerase—ESR1—migraine	0.00119	0.0095	CbGpPWpGaD
Pimecrolimus—Erythema—Timolol—migraine	0.00119	0.00257	CcSEcCtD
Pimecrolimus—Malnutrition—Timolol—migraine	0.00119	0.00257	CcSEcCtD
Pimecrolimus—Eye disorder—Gabapentin—migraine	0.00119	0.00256	CcSEcCtD
Pimecrolimus—MTOR—IL12-mediated signaling events—FOS—migraine	0.00119	0.00946	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—PGR—migraine	0.00118	0.00935	CbGpPWpGaD
Pimecrolimus—Cough—Valproic Acid—migraine	0.00117	0.00251	CcSEcCtD
Pimecrolimus—Conjunctivitis—Topiramate—migraine	0.00116	0.0025	CcSEcCtD
Pimecrolimus—Immune system disorder—Gabapentin—migraine	0.00115	0.00248	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Gabapentin—migraine	0.00115	0.00247	CcSEcCtD
Pimecrolimus—Diarrhoea—Propranolol—migraine	0.00115	0.00247	CcSEcCtD
Pimecrolimus—Arthralgia—Valproic Acid—migraine	0.00114	0.00245	CcSEcCtD
Pimecrolimus—Hypersensitivity—Verapamil—migraine	0.00114	0.00244	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00113	0.00244	CcSEcCtD
Pimecrolimus—Epistaxis—Topiramate—migraine	0.00113	0.00243	CcSEcCtD
Pimecrolimus—Sinusitis—Topiramate—migraine	0.00112	0.00241	CcSEcCtD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—FOS—migraine	0.00112	0.00888	CbGpPWpGaD
Pimecrolimus—Erythema—Gabapentin—migraine	0.00111	0.00239	CcSEcCtD
Pimecrolimus—Malnutrition—Gabapentin—migraine	0.00111	0.00239	CcSEcCtD
Pimecrolimus—MTOR—Leptin signaling pathway—ESR1—migraine	0.0011	0.00878	CbGpPWpGaD
Pimecrolimus—MTOR—TSH signaling pathway—FOS—migraine	0.0011	0.00877	CbGpPWpGaD
Pimecrolimus—Anaphylactic shock—Valproic Acid—migraine	0.00109	0.00235	CcSEcCtD
Pimecrolimus—Oedema—Valproic Acid—migraine	0.00109	0.00235	CcSEcCtD
Pimecrolimus—Pruritus—Verapamil—migraine	0.00109	0.00235	CcSEcCtD
Pimecrolimus—Angioedema—Timolol—migraine	0.00109	0.00234	CcSEcCtD
Pimecrolimus—Infection—Valproic Acid—migraine	0.00109	0.00234	CcSEcCtD
Pimecrolimus—MTOR—Regulation of Telomerase—FOS—migraine	0.00108	0.00856	CbGpPWpGaD
Pimecrolimus—Rhinitis—Topiramate—migraine	0.00108	0.00231	CcSEcCtD
Pimecrolimus—Back pain—Gabapentin—migraine	0.00107	0.00231	CcSEcCtD
Pimecrolimus—Nervous system disorder—Valproic Acid—migraine	0.00107	0.00231	CcSEcCtD
Pimecrolimus—Vomiting—Propranolol—migraine	0.00107	0.00229	CcSEcCtD
Pimecrolimus—Pharyngitis—Topiramate—migraine	0.00106	0.00229	CcSEcCtD
Pimecrolimus—Skin disorder—Valproic Acid—migraine	0.00106	0.00228	CcSEcCtD
Pimecrolimus—Rash—Propranolol—migraine	0.00106	0.00227	CcSEcCtD
Pimecrolimus—Dermatitis—Propranolol—migraine	0.00106	0.00227	CcSEcCtD
Pimecrolimus—Diarrhoea—Verapamil—migraine	0.00105	0.00227	CcSEcCtD
Pimecrolimus—Cough—Timolol—migraine	0.00104	0.00224	CcSEcCtD
Pimecrolimus—Arthralgia—Timolol—migraine	0.00101	0.00218	CcSEcCtD
Pimecrolimus—Angioedema—Gabapentin—migraine	0.00101	0.00218	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00101	0.00217	CcSEcCtD
Pimecrolimus—Eye disorder—Topiramate—migraine	0.001	0.00216	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Valproic Acid—migraine	0.000996	0.00214	CcSEcCtD
Pimecrolimus—Flushing—Topiramate—migraine	0.000996	0.00214	CcSEcCtD
Pimecrolimus—Nausea—Propranolol—migraine	0.000995	0.00214	CcSEcCtD
Pimecrolimus—Paraesthesia—Valproic Acid—migraine	0.000981	0.00211	CcSEcCtD
Pimecrolimus—Vomiting—Verapamil—migraine	0.00098	0.00211	CcSEcCtD
Pimecrolimus—Dyspnoea—Valproic Acid—migraine	0.000974	0.0021	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Timolol—migraine	0.000973	0.00209	CcSEcCtD
Pimecrolimus—Oedema—Timolol—migraine	0.000973	0.00209	CcSEcCtD
Pimecrolimus—Rash—Verapamil—migraine	0.000972	0.00209	CcSEcCtD
Pimecrolimus—Dermatitis—Verapamil—migraine	0.000971	0.00209	CcSEcCtD
Pimecrolimus—Immune system disorder—Topiramate—migraine	0.000969	0.00209	CcSEcCtD
Pimecrolimus—Cough—Gabapentin—migraine	0.000969	0.00208	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Topiramate—migraine	0.000967	0.00208	CcSEcCtD
Pimecrolimus—Infection—Timolol—migraine	0.000966	0.00208	CcSEcCtD
Pimecrolimus—Headache—Verapamil—migraine	0.000966	0.00208	CcSEcCtD
Pimecrolimus—Nervous system disorder—Timolol—migraine	0.000954	0.00205	CcSEcCtD
Pimecrolimus—Arthralgia—Gabapentin—migraine	0.000945	0.00203	CcSEcCtD
Pimecrolimus—Skin disorder—Timolol—migraine	0.000945	0.00203	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Valproic Acid—migraine	0.000943	0.00203	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000938	0.00202	CcSEcCtD
Pimecrolimus—Constipation—Valproic Acid—migraine	0.000934	0.00201	CcSEcCtD
Pimecrolimus—Pain—Valproic Acid—migraine	0.000934	0.00201	CcSEcCtD
Pimecrolimus—Malnutrition—Topiramate—migraine	0.000934	0.00201	CcSEcCtD
Pimecrolimus—Erythema—Topiramate—migraine	0.000934	0.00201	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000929	0.00739	CbGpPWpGaD
Pimecrolimus—Nausea—Verapamil—migraine	0.000915	0.00197	CcSEcCtD
Pimecrolimus—Oedema—Gabapentin—migraine	0.000906	0.00195	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Gabapentin—migraine	0.000906	0.00195	CcSEcCtD
Pimecrolimus—Back pain—Topiramate—migraine	0.000903	0.00194	CcSEcCtD
Pimecrolimus—Infection—Gabapentin—migraine	0.0009	0.00194	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Valproic Acid—migraine	0.000894	0.00192	CcSEcCtD
Pimecrolimus—CYP3A4—nervous system—migraine	0.00089	0.012	CbGeAlD
Pimecrolimus—Nervous system disorder—Gabapentin—migraine	0.000888	0.00191	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Timolol—migraine	0.000886	0.00191	CcSEcCtD
Pimecrolimus—Skin disorder—Gabapentin—migraine	0.00088	0.00189	CcSEcCtD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000874	0.00695	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—BDNF—migraine	0.000874	0.00695	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Timolol—migraine	0.000874	0.00188	CcSEcCtD
Pimecrolimus—Urticaria—Valproic Acid—migraine	0.000868	0.00187	CcSEcCtD
Pimecrolimus—Dyspnoea—Timolol—migraine	0.000867	0.00187	CcSEcCtD
Pimecrolimus—Abdominal pain—Valproic Acid—migraine	0.000864	0.00186	CcSEcCtD
Pimecrolimus—Body temperature increased—Valproic Acid—migraine	0.000864	0.00186	CcSEcCtD
Pimecrolimus—CYP3A4—central nervous system—migraine	0.000857	0.0115	CbGeAlD
Pimecrolimus—Gastrointestinal disorder—Timolol—migraine	0.00084	0.00181	CcSEcCtD
Pimecrolimus—Pain—Timolol—migraine	0.000832	0.00179	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Gabapentin—migraine	0.000825	0.00178	CcSEcCtD
Pimecrolimus—Cough—Topiramate—migraine	0.000815	0.00175	CcSEcCtD
Pimecrolimus—Paraesthesia—Gabapentin—migraine	0.000813	0.00175	CcSEcCtD
Pimecrolimus—Dyspnoea—Gabapentin—migraine	0.000808	0.00174	CcSEcCtD
Pimecrolimus—Hypersensitivity—Valproic Acid—migraine	0.000805	0.00173	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Timolol—migraine	0.000795	0.00171	CcSEcCtD
Pimecrolimus—Arthralgia—Topiramate—migraine	0.000795	0.00171	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.00079	0.0017	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Gabapentin—migraine	0.000782	0.00168	CcSEcCtD
Pimecrolimus—Constipation—Gabapentin—migraine	0.000775	0.00167	CcSEcCtD
Pimecrolimus—Pain—Gabapentin—migraine	0.000775	0.00167	CcSEcCtD
Pimecrolimus—Pruritus—Valproic Acid—migraine	0.000773	0.00166	CcSEcCtD
Pimecrolimus—Urticaria—Timolol—migraine	0.000773	0.00166	CcSEcCtD
Pimecrolimus—Abdominal pain—Timolol—migraine	0.000769	0.00166	CcSEcCtD
Pimecrolimus—Body temperature increased—Timolol—migraine	0.000769	0.00166	CcSEcCtD
Pimecrolimus—Oedema—Topiramate—migraine	0.000762	0.00164	CcSEcCtD
Pimecrolimus—MTOR—ErbB1 downstream signaling—FOS—migraine	0.00076	0.00605	CbGpPWpGaD
Pimecrolimus—Infection—Topiramate—migraine	0.000757	0.00163	CcSEcCtD
Pimecrolimus—Diarrhoea—Valproic Acid—migraine	0.000748	0.00161	CcSEcCtD
Pimecrolimus—Nervous system disorder—Topiramate—migraine	0.000747	0.00161	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Gabapentin—migraine	0.000741	0.00159	CcSEcCtD
Pimecrolimus—Skin disorder—Topiramate—migraine	0.00074	0.00159	CcSEcCtD
Pimecrolimus—Urticaria—Gabapentin—migraine	0.00072	0.00155	CcSEcCtD
Pimecrolimus—Hypersensitivity—Timolol—migraine	0.000717	0.00154	CcSEcCtD
Pimecrolimus—Body temperature increased—Gabapentin—migraine	0.000716	0.00154	CcSEcCtD
Pimecrolimus—Abdominal pain—Gabapentin—migraine	0.000716	0.00154	CcSEcCtD
Pimecrolimus—Vomiting—Valproic Acid—migraine	0.000695	0.0015	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Topiramate—migraine	0.000694	0.00149	CcSEcCtD
Pimecrolimus—Rash—Valproic Acid—migraine	0.000689	0.00148	CcSEcCtD
Pimecrolimus—Dermatitis—Valproic Acid—migraine	0.000688	0.00148	CcSEcCtD
Pimecrolimus—Pruritus—Timolol—migraine	0.000688	0.00148	CcSEcCtD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—TNF—migraine	0.000686	0.00545	CbGpPWpGaD
Pimecrolimus—Headache—Valproic Acid—migraine	0.000685	0.00147	CcSEcCtD
Pimecrolimus—Paraesthesia—Topiramate—migraine	0.000684	0.00147	CcSEcCtD
Pimecrolimus—Dyspnoea—Topiramate—migraine	0.000679	0.00146	CcSEcCtD
Pimecrolimus—Hypersensitivity—Gabapentin—migraine	0.000667	0.00144	CcSEcCtD
Pimecrolimus—Diarrhoea—Timolol—migraine	0.000666	0.00143	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TNF—migraine	0.000662	0.00527	CbGpPWpGaD
Pimecrolimus—Gastrointestinal disorder—Topiramate—migraine	0.000658	0.00142	CcSEcCtD
Pimecrolimus—Constipation—Topiramate—migraine	0.000652	0.0014	CcSEcCtD
Pimecrolimus—Pain—Topiramate—migraine	0.000652	0.0014	CcSEcCtD
Pimecrolimus—Nausea—Valproic Acid—migraine	0.000649	0.0014	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—CALCRL—migraine	0.000649	0.00516	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RAMP1—migraine	0.000649	0.00516	CbGpPWpGaD
Pimecrolimus—Pruritus—Gabapentin—migraine	0.000641	0.00138	CcSEcCtD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—ESR1—migraine	0.000631	0.00502	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—ESR1—migraine	0.000627	0.00499	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Topiramate—migraine	0.000623	0.00134	CcSEcCtD
Pimecrolimus—Diarrhoea—Gabapentin—migraine	0.00062	0.00133	CcSEcCtD
Pimecrolimus—Vomiting—Timolol—migraine	0.000619	0.00133	CcSEcCtD
Pimecrolimus—Rash—Timolol—migraine	0.000613	0.00132	CcSEcCtD
Pimecrolimus—Dermatitis—Timolol—migraine	0.000613	0.00132	CcSEcCtD
Pimecrolimus—Headache—Timolol—migraine	0.000609	0.00131	CcSEcCtD
Pimecrolimus—Urticaria—Topiramate—migraine	0.000605	0.0013	CcSEcCtD
Pimecrolimus—Body temperature increased—Topiramate—migraine	0.000602	0.0013	CcSEcCtD
Pimecrolimus—Abdominal pain—Topiramate—migraine	0.000602	0.0013	CcSEcCtD
Pimecrolimus—MTOR—BDNF signaling pathway—FOS—migraine	0.000591	0.0047	CbGpPWpGaD
Pimecrolimus—Nausea—Timolol—migraine	0.000578	0.00124	CcSEcCtD
Pimecrolimus—Vomiting—Gabapentin—migraine	0.000576	0.00124	CcSEcCtD
Pimecrolimus—Rash—Gabapentin—migraine	0.000571	0.00123	CcSEcCtD
Pimecrolimus—Dermatitis—Gabapentin—migraine	0.000571	0.00123	CcSEcCtD
Pimecrolimus—Headache—Gabapentin—migraine	0.000568	0.00122	CcSEcCtD
Pimecrolimus—Hypersensitivity—Topiramate—migraine	0.000562	0.00121	CcSEcCtD
Pimecrolimus—FKBP1A—Disease—LRP1—migraine	0.000551	0.00438	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin Signaling—FOS—migraine	0.000543	0.00432	CbGpPWpGaD
Pimecrolimus—Pruritus—Topiramate—migraine	0.000539	0.00116	CcSEcCtD
Pimecrolimus—Nausea—Gabapentin—migraine	0.000538	0.00116	CcSEcCtD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—FOS—migraine	0.000537	0.00428	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Topiramate—migraine	0.000521	0.00112	CcSEcCtD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000501	0.00398	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000489	0.00389	CbGpPWpGaD
Pimecrolimus—Vomiting—Topiramate—migraine	0.000485	0.00104	CcSEcCtD
Pimecrolimus—Rash—Topiramate—migraine	0.000481	0.00103	CcSEcCtD
Pimecrolimus—Dermatitis—Topiramate—migraine	0.00048	0.00103	CcSEcCtD
Pimecrolimus—Headache—Topiramate—migraine	0.000477	0.00103	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR1D—migraine	0.000471	0.00375	CbGpPWpGaD
Pimecrolimus—Nausea—Topiramate—migraine	0.000453	0.000974	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.00045	0.00358	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR2B—migraine	0.000438	0.00349	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—LRP1—migraine	0.000386	0.00307	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CALCRL—migraine	0.000365	0.0029	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RAMP1—migraine	0.000365	0.0029	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—FOS—migraine	0.000364	0.00289	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CALCA—migraine	0.000355	0.00282	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—LRP1—migraine	0.00031	0.00246	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOTCH4—migraine	0.000296	0.00235	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFBR2—migraine	0.000286	0.00227	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR1B—migraine	0.000286	0.00227	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR1A—migraine	0.000275	0.00219	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PGR—migraine	0.000271	0.00215	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NPS—migraine	0.000271	0.00215	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TAC1—migraine	0.000271	0.00215	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR2C—migraine	0.000265	0.00211	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR1D—migraine	0.000265	0.00211	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EDNRA—migraine	0.000258	0.00205	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOTCH3—migraine	0.000252	0.002	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CALCA—migraine	0.000249	0.00198	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR2B—migraine	0.000246	0.00196	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR7—migraine	0.000232	0.00185	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—MTHFR—migraine	0.000232	0.00185	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LRP1—migraine	0.000217	0.00173	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFBR2—migraine	0.0002	0.00159	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CALCA—migraine	0.0002	0.00159	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—FOS—migraine	0.000195	0.00155	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOTCH4—migraine	0.000166	0.00132	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR2A—migraine	0.000163	0.0013	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFBR2—migraine	0.000161	0.00128	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR1B—migraine	0.000161	0.00128	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR1A—migraine	0.000155	0.00123	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TAC1—migraine	0.000152	0.00121	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NPS—migraine	0.000152	0.00121	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PGR—migraine	0.000152	0.00121	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR2C—migraine	0.000149	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EDNRA—migraine	0.000145	0.00116	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ESR1—migraine	0.000145	0.00115	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOTCH3—migraine	0.000142	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CALCA—migraine	0.00014	0.00111	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR7—migraine	0.000131	0.00104	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—MTHFR—migraine	0.000131	0.00104	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—FOS—migraine	0.000113	0.000901	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFBR2—migraine	0.000113	0.000896	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR2A—migraine	9.16e-05	0.000728	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CACNA1A—migraine	8.77e-05	0.000698	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ESR1—migraine	8.13e-05	0.000647	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MTHFR—migraine	2.9e-05	0.000231	CbGpPWpGaD
